$ABOS

12 Health Care Stocks Moving In Monday's Pre-Market Session

This article lists 12 healthcare stocks experiencing significant movement in Monday's pre-market session. It highlights both gainers and losers, providing their current stock prices, percentage changes, and market capitalizations. Companies like Acumen Pharmaceuticals and Dermata Therapeutics saw gains, while 60 Degrees Pharmaceuticals and Revolution Medicines experienced declines.

Original reporting
Benzinga · Benzinga Insights, Benzinga Staff Writer
Published Jan 26, 2026, 12:09 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jan 26, 2026, 1:01 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
12 Health Care Stocks Moving In Monday's Pre-Market Session — source image
Decision brief

The 30-second read

$ABOSBullishMed
01

Why it matters

Pre-market activity suggests increased trader interest and potential volatility in the healthcare sector.

02

Market read

The movements reflect sector-specific dynamics, with potential implications for related healthcare stocks.

03

What to watch

Broader market conditions and sector news could influence stock performance beyond pre-market indicators.

Timing: Immediate; pre-market movements can influence intraday trading decisions.

Background

The article reports significant pre-market movements in 12 healthcare stocks, highlighting both gainers and losers, which can influence intraday trading strategies.

Company-level read

Ticker impact

$ABOSBullishHigh confidence
Context

High relevance due to bullish sentiment and significant pre-market movement.

Expected impact

Moderate increase in stock price expected during the trading session.

Evidence & confidence

The bullish sentiment score of 0.518226 and pre-market gains suggest strong buying interest, supported by positive industry trends.

Market effects

The healthcare sector may experience increased volatility due to pre-market movements, potentially affecting related stocks.

Limited regional impact; movements are specific to individual stocks.

Minimal; sector-specific news with limited global implications.

Counterpoint

Pre-market gains may be temporary; a reversal could occur during regular trading hours due to profit-taking or sector rotation.

Key entities

  • Acumen Pharmaceuticals

    A biotech company focusing on rare disease therapeutics.

  • Dermata Therapeutics

    A clinical-stage dermatology-focused biotech.

  • 60 Degrees Pharmaceuticals

    A pharmaceutical firm experiencing declines in pre-market trading.

  • Revolution Medicines

    A biotech company with recent stock declines.

Related articles

$ETNMed

Eaton Gains on $7-Million Contract

Eaton (NYSE:ETN) said the U.S. Air Force Research Laboratory awarded it a $7 million, 24-month contract to use quantum computing, machine learning, and advanced visualization to improve power grid resilience and protection. The work, with Infleqtion and Penn State, targets detection and response to multiple concurrent physical and cyber threats, addressing NERC N-2 contingency requirements.

$XOMMed

ExxonMobil awards McDermott engineering work for Rovuma LNG

ExxonMobil Moçambique Limitada issued McDermott Energy Solutions (UK) a letter of intent for limited engineering and procurement work on Rovuma LNG Phase 1 midstream development. The award supports planning ahead of a final investment decision expected in 2026. Rovuma LNG targets 12 modular trains totaling 18.6 mtpa, with start-up in 2031. ExxonMobil says the 30-year project could generate about $150B in revenues for Mozambique’s government.

$ESLTMed

Serbia to open joint UAV factory with Elbit in September

Serbia President Aleksandar Vucic said Serbia will open a joint UAV factory with Elbit Systems, with inauguration expected Sept 15-20. Elbit will hold 51% and Serbia’s state arms firm SDPR 49%. The factory relates to a five-year contract covering precision rockets and unmanned systems, plus ISTAR, digitization and upgrades.

$NOCMed

The Pentagon is urging defense contractors to urgently ramp up weapons production – WP

The U.S. Department of Defense, according to The Washington Post, asked defense contractors to submit within 21 days production and delivery schedules for critical systems, citing depleted stockpiles. CSIS estimates cite heavy early use of missiles and falling Patriot and THAAD inventories. The Pentagon is working with Northrop Grumman and Lockheed Martin, including a $58.6B deal to triple PAC-3 output by 2030, pending a stalled $1.15T defense budget.

$LMTMed

Pentagon pushes military contractors to accelerate production amid shortages after war on Iran

The Pentagon ordered US defense contractors to submit within 21 days plans to accelerate production of missiles and interceptors amid shortages after the first month of strikes against Iran. It cited depleted Patriot and THAAD inventories and said framework agreements with Lockheed Martin and Northrop Grumman target PAC-3 and THAAD output. Lockheed Martin received a contract up to $58.6B to triple PAC-3 production by 2030.

$NOCMed

WP: Pentagon asks defense companies to urgently ramp up weapons production

The Pentagon, via Deputy Secretary Steve Feinberg, urged U.S. defense firms to accelerate weapons output, especially ammunition, and asked executives to submit production and delivery plans within 21 days, according to The Washington Post. CSIS data cited Patriot and THAAD stockpiles falling sharply. The article notes talks with Northrop Grumman and Lockheed Martin and a Lockheed contract up to $58.6B to triple PAC-3 output by 2030.